eine Presse / Telefonkonferenz /
[b]XSPA vorbörslich + 52 % old.nasdaq.com/symbol/xspa/premarket
" XSPA(.22) seeks to support COVID-19 testing in 46 locations across 23 US Airports
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), today announced that it has reached out to multiple government agencies, including the Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health and Human Services (HHS), as well as private laboratories across the country.
The Company has engaged in early high-level discussions with regards to turning all of its 46 airport locations, with many, located in point of entry cities, such as New York, Los Angeles, San Francisco, Chicago, Miami, Atlanta, and Washington DC into COVID-19 testing facilities. The Company believes that its spas offer a range of spaces that can be set up to test airport staff, flight crews, and passengers.
The international airports across the United States are on the front lines of defense for combating entry into the US for people with the Cronavirus. Xpresspa, having locations in all of these key ports of entry is uniquely positioned to help in this fight. As a health and wellness company the majority of its employees are state licensed which includes training in disease containment. In addition, XpresSpa employees are already TSA security approved so they can be trained and deployed immediately.
Doug Satzman, XpresSpa, Chief Executive Officer, said, ”We believe we can we help alleviate some of the long waits for travelers entering the US but we can also be available to test TSA employees, pilots, Flight Attendants and other airport personnel who are on the front lines helping to keep our nation safe.”
Doug Satzman, further stated “As the largest operator of health and wellness spas located within these US point of entry airports, we believe our facilities could be of great utility in helping our government test people as quickly as possible. We will work closely with local airport authorities on all plans. While we cannot ensure that an arrangement will ultimately be consummated, we remain optimistic, that we can play a vital role with some of these entities.”
secfilings.nasdaq.com/...0INC.&FormType=8-K&View=html
-----------------
XpresSpa Announces Partnership with Relevant Healthcare
GlobeNewswire GlobeNewswire•March 25, 2020
Novel Coronavirus (COVID-19) Testing in U.S. Airports
NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (XSPA) (“XpresSpa” or the “Company”), today announced an update to discussions in converting its spa locations into novel coronavirus (“COVID-19”) testing locations.
XpresSpa will be partnering (the “Partnership”) with Relevant Healthcare Cost Containment®, the registered trade name of Contain Holdings, LLC, an Illinois limited liability company (“Relevant Healthcare”), a Chicago-area healthcare cost containment, payment integrity and transparency company. Relevant Healthcare had previously announced that it is offering testing for COVID-19 (the “COVID-19 testing”) through its contracts with both Laboratory Corporation of America® (“LabCorp”) and Quest Diagnostics™ (“Quest”). Both LabCorp and Quest are the leading laboratory companies in the U.S. and have the current capacity to process tens of thousands of COVID-19 tests per day. All COVID-19 testing will be done by appropriately licensed health professionals in accordance with applicable federal and state laws.
With our global spas temporarily closing due to recent local government mandates categorizing our traditional services as “non-essential services”, XpresSpa is actively advancing conversations with COVID-19 testing partners to develop a model for testing in U.S. airports including point of entry cities such as New York, Los Angeles, San Francisco, Chicago, Miami, Atlanta and Washington D.C. We have had dialog with the offices of U.S. Senators, Governors, federal authorities and other various agencies to assist in the effort to expedite COVID-19 testing as a much-needed public service.
Our airport real estate portfolio of 46 locations across 23 U.S. airports is ready to reactivate and be redeployed in partnership with local airport authorities in short order.
Doug Satzman, CEO, XpresSpa said, “This is a rapidly developing environment with private and public sectors working in unprecedented ways to partner for the benefit and protection of our citizens. We believe XpresSpa has a significant role to play in the fight against COVID-19 within the travel sector given our airport relationships, infrastructure, workforce with TSA clearance and strong desire to keep travelers and those who work in the airline industries safe.”
When approached by XpresSpa with a potential partnership, Raymond McGaugh, CEO, Relevant Healthcare responded, “I believe this is much needed as the U.S. is mobilizing to implement the first part of the recognized strategy to combat the COVID-19 pandemic, which is mitigation with social distancing, and is rapidly moving to implement the second step of testing for the COVID-19 virus on a mass scale to combat the pandemic. U.S. airports are undoubtedly one of the most important gateway targets with a large population of U.S. airport workers, vendors, TSA security and screeners personnel, airline personnel and, of course, travelers.”
XpresSpa has a significant role to play in the fight against COVID-19 as we, as a nation, become more vigilant in fighting the spread of COVID-19 and other highly contagious diseases in the future. We hope to use our infrastructure and the processes being developed today to work in coordination with the federal and state governments to assist in combating future pandemics.
ca.finance.yahoo.com/news/...levant-healthcare-130010579.html "
